Eli Lilly plans to introduce Mounjaro (tirzepatide) in India by 2025, while Biocon has made regulatory filings for GLP-1 receptor agonists in various markets, including India, to expand its portfolio in the obesity and diabetes treatment segments
When meals get smaller, muscle tissue becomes more vulnerable to breakdown, so hitting a daily protein target matters more
Adonis Saremis specialized expertise in Obesity Medicine makes him uniquely qualified to design and supervise a safe, effective microdosing program for Irvine patients
Individuals have varying sensitivities to medications
Older adults can use this site if the muscle in their upper arm, their deltoid, is well developed
However, these treatments are not without risks, and their use should always be guided by a healthcare professional